The Safety and Efficacy of CPTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors
This study has been completed.
Sponsor:
University of Iowa
Collaborator:
Novartis Pharmaceuticals
Information provided by:
University of Iowa
ClinicalTrials.gov Identifier:
NCT00627198
First received: February 20, 2008
Last updated: December 1, 2010
Last verified: December 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2010 |
| Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |